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Peroxisomal matrix proteins are synthesized on cytosolic ribosomes and trans-
ported by the shuttling receptor PEX5 to the peroxisomal membrane docking/
translocation machinery, where they are translocated into the organelle matrix.
Under certain experimental conditions this protein import machinery has the
remarkable capacity to accept already oligomerized proteins, a property that
has heavily influenced current models on the mechanism of peroxisomal protein
import. However, whether or not oligomeric proteins are really the best and
most frequent clients of this machinery remain unclear. In this work, we present
three lines of evidence suggesting that the peroxisomal import machinery dis-
plays a preference for monomeric proteins. First, in agreement with previous
findings on catalase, we show that PEX5 binds newly synthesized (monomeric)
acyl-CoA oxidase 1 (ACOX1) and urate oxidase (UOX), potently inhibiting their
oligomerization. Second, in vitro import experiments suggest that monomeric
ACOX1 and UOX are better peroxisomal import substrates than the correspond-
ing oligomeric forms. Finally, we provide data strongly suggesting that although
ACOX1 lacking a peroxisomal targeting signal can be imported into peroxisomes
when co-expressed with ACOX1 containing its targeting signal, this import
pathway is inefficient.2. Introduction
Peroxisomes are single membrane-bounded organelles that participate in many
biochemical pathways [1–4]. In mammals, they have a relatively simple protein
repertoire, harbouring about 50 enzymes in their matrix [5,6]. All these proteins
are synthesized on cytosolic ribosomes and post-translationally targeted to the
organelle matrix [7]. Their correct sorting relies on one of two peroxisomal
targeting signals (PTS): the PTS type 1 (PTS1), a C-terminal peptide generally
ending with the sequence Ser-Lys-Leu, found in the vast majority of peroxiso-
mal matrix proteins [8,9]; and the PTS2, a degenerate nonapeptide present at
the N-termini of just a few proteins [10–12].
According to current models [13–16], newly synthesized peroxisomal matrix
proteins are recognized by the shuttling receptor PEX5 while still in the cytosol
[17]. PTS1proteinsbinddirectly toPEX5,whereasPTS2proteins require theancillary
protein PEX7 to interact with PEX5 [8,12,18–21]. Following this recognition event,
the PEX5(.PEX7)–cargo protein complex interacts with the docking/translocation
machinery (DTM) [22–24], a multisubunit transmembrane protein complex of the
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insertion of PEX5 into theDTMwith the concomitant transloca-
tion of the cargo protein across the organelle membrane
[23,24,27,28]. Remarkably, none of these steps requires cytosolic
nucleoside triphosphates [23,24,28,29], a property that led to the
proposal that the driving force for the cargo translocation pro-
cess resides on the strong protein–protein interactions that are
established between PEX5 on one side and components of the
DTM on the other [29,30]. After cargo translocation, PEX5 is
extracted from the DTM [23,24,28], a process that requires its
monoubiquitination at a conserved cysteine residue [31,32]
and the ATP-dependent action of the mechano-enzymes PEX1
and PEX6 [29,33,34]. Once in the cytosol, monoubiquitinated
PEX5 is deubiquitinated, probably by a combination of enzy-
matic and non-enzymatic mechanisms, thus resetting the
peroxisomal import machinery (PIM) [35–37].
Although our knowledge on the general properties of
the PIM is fairly detailed, there are still many fundamental
aspects of this protein import pathway that remain ill-defined.
An important one regards the structure of the cargo proteins
accepted by the PIM. It is a widely accepted fact that peroxi-
somes can import already oligomerized proteins. The data
supporting this idea are abundant and include (i) several studies
showing thatwhen two interacting proteins are expressed in the
same cell, the presence of a single PTS in one of those proteins is
sufficient to ensure targeting of at least a fraction of the other
protein to the peroxisome [38–44] and (ii) pulse–chase analyses
on yeasts suggesting that two peroxisomal matrix enzymes oli-
gomerize in the cytosol prior to import [45,46]. Collectively,
these data led to the generalization that most peroxisomal pro-
teins oligomerize in the cytosol before import, a concept that
can be found in many reviews and even in academic textbooks
[15,47–51]. However, it should be noted that all of the above
cited studies focused on proteins that were overexpressed,
either through the use of recombinant genes having strong pro-
moters or, in the case of yeasts/fungi, by simply growing these
organisms in special media that induce a dramatic proliferation
of peroxisomes. Such experimental conditions can potentially
lead to the titration of the PIM (e.g. PEX5 and/or PEX7) and
thus to the premature oligomerization of those proteins in the
cytosol. Naturally, this caveat does not affect the main con-
clusion of all those studies, namely that the PIM, in contrast to
the protein import machineries of mitochondria and endoplas-
mic reticulum, has the capacity to accept bulky/already folded
clients [39,40]. However, in the absence of additional data, it
remains unclear how frequent and efficient the import of
already oligomerized proteins into peroxisomes is, an uncer-
tainty that limits our understanding on the mechanism of the
PIM (see below).
The uncertainty regarding the concept that most peroxiso-
mal proteins are imported as oligomers is also fed by a
number of previous findings. For instance, pulse–chase ana-
lyses have shown that rat liver catalase (a homo-tetrameric
enzyme in its native state) and Candida boidinii alcohol oxi-
dase (an octameric enzyme) arrive at the peroxisome still as
monomers [52,53]. Also, some data suggesting that plant
monomeric isocitrate lyase (a homo-tetrameric enzyme in
its native state) is a better import substrate than the already
tetrameric enzyme have been provided [54]. In line with
these findings it was subsequently reported that (monomeric)
serum albumin containing a PTS is also imported into peroxi-
somes, clearly showing that cargo proteins do not have to be
oligomers in order to be accepted by the PIM [55]. Finally,there are at least three peroxisomal matrix proteins that no
longer bind PEX5 upon oligomerization. These are alcohol
oxidase from Hansenula polymorpha and mammalian carbonyl
reductase and epoxide hydrolase [56–58]. Seemingly, at least
in these cases, the proteins have to remain monomeric in
order to be imported into peroxisomes.
Determining the type of substrate preferred by the PIM is of
major importance to understand its mechanism. If we assume
that almost all oligomeric peroxisomal proteins oligomerize in
the cytosol prior to import, then import of oligomeric cargoes
becomes the rule for protein translocation across the peroxiso-
mal membrane, because most peroxisomal matrix proteins are
indeed homo-oligomers [48]. This is the scenario behind some
previous models proposing that cargoes (containing multiple
PTSs due to their oligomeric nature) are presented to the DTM
by multiple molecules of PEX5 [48,49]. If, instead, we assume
that under normal physiological conditions newly synthesized
matrix proteins are kept in a monomeric near-native confor-
mation until they arrive at the organelle matrix, then a model
in which a single PEX5 molecule delivers a single cargo to the
DTM is more likely [59,60]. The outcomes of each of these
assumptions to the cargo protein translocation step are quite
different because, as stated above, all the available data suggest
that cargo proteins are translocated across the organelle mem-
brane by PEX5 itself, when the receptor becomes inserted into
the DTM. Thus, the first scenariowould predict that each oligo-
meric cargo is translocated by several PEX5 molecules (see [15]
for a mechanism of this type), whereas in the second scenario a
single PEX5 molecule would suffice [59].
Previously, we found that PEX5 at physiological con-
centrations binds monomeric catalase, potently blocking its
tetramerization [61]. This property, together with the fact that
there is sufficient PEX5 in rat hepatocyte cytosol to bind all
newly synthesizedperoxisomalmatrix proteins, led us to hypoth-
esize that PEX5, in addition to its role as a receptor and
translocator, is also a chaperone/holdase, binding newly syn-
thesized monomeric proteins in the cytosol and inhibiting
premature or incorrect interactions [61]. In this work, we have
characterized the import pathway of acyl-CoA oxidase 1
(ACOX1; a homo-dimeric protein in its native state [62]) and
urate oxidase (UOX; a homo-tetramer [63]), two peroxisomal
matrix proteins which together with catalase comprise one-third
of the total protein molecules found in mouse/rat liver peroxiso-
malmatrix [62,64].We found thatPEX5alsobinds themonomeric
version of these proteins, blocking their homo-oligomerization.
Importantly, peroxisomal import assays suggest that the mono-
meric versions of ACOX1 and UOX are much better substrates
for the PIM than the corresponding homo-oligomeric versions.
Altogether, these results suggest that import of monomeric pro-
teins into the peroxisome is not a phenomenon restricted to a
few particular clients. Rather, at the very least, our data raise the
possibility thatmanyof the protein translocation events occurring
at the PIM involve monomeric cargoes.3. Results
3.1. PEX5 inhibits dimerization of newly synthesized
acyl-CoA oxidase 1
We have recently shown that a rabbit reticulocyte lysate-
based in vitro translation system can be used to prepare
monomeric and tetrameric versions of catalase. The amount
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dent: synthesis reactions performed for a short period of time
yielded essentially monomeric catalase; longer incubations
led to the conversion of a fraction of the monomeric protein
into tetrameric catalase, a process that was strongly inhibi-
ted by PEX5 [61]. Here, we determined whether the same
experimental strategy could be applied to other oligomeric
peroxisomal matrix proteins. The aim was twofold: (i) to
characterize the effect of PEX5 on their oligomerization pro-
cess and (ii) to obtain monomeric and oligomeric versions
of these proteins so that their in vitro peroxisomal import
competences could be compared (note that all our attempts
to import monomeric or tetrameric catalase into rat/mouse
liver peroxisomes have failed thus far, probably because the
PEX5–catalase interaction is too transient, and therefore too
sensitive to the competition exerted by endogenous (liver)
soluble PTS1 proteins present in these in vitro assays;
T Francisco, JE Azevedo, unpublished observations, see also
[23]). We focused mainly on ACOX1, but some experiments
were repeated with another peroxisomal matrix protein (see
later). Native ACOX1 comprises two identical 74 kDa sub-
units, each of which is partially and slowly cleaved in the
peroxisomal matrix in vivo into an N-terminal domain of
53 kDa and a C-terminal 21 kDa polypeptide [65–67].
We first used an immunoprecipitation assay to assess
whether ACOX1 can interactwith itself in the in vitro translation
system. As shown in figure 1a, upper panel, when ACOX1 and
an epitope-tagged version of it containing two haemagglutinin
(HA) sequences at the N-terminus (2HA-ACOX1) were co-
synthesized in vitro for 30 min, chased in the presence of cyclo-
heximide for 4 h, and subjected to immunoprecipitation using
an anti-HA antibody, a significant amount of ACOX1 was co-
immunoprecipitated with 2HA-ACOX1 (lane 7). No ACOX1
was recovered in immunoprecipitates when the two proteins
were synthesized separately for 30 min and mixed just before
immunoprecipitation, or when the co-synthesis and chase incu-
bations were performed in the presence of recombinant PEX5
(figure 1a, upper panel, lanes 6 and 8, respectively). For reasons
that will become apparent below, we used the same strategy to
determine whether 2HA-ACOX1 can interact with an ACOX1
species possessing a Flag epitope at its C-terminus (ACOX1-
Flag). The results shown in figure 1a, lower panel, suggest that
this is indeed the case.
In another approach, we used sucrose gradient centrifu-
gation to characterize the sedimentation behaviour of in vitro
synthesizedACOX1.As shown in figure 1b,ACOX1synthesized
for just 30 min sedimented as a globular monomeric protein,
together with albumin, a 67 kDa protein (panel I, lane 6). We
refer to this species as monomeric ACOX1 (mACOX1). When
mACOX1 was chased for 4 h in the presence of cycloheximide,
a second ACOX1 population was detected in these gradients
(figure 1b, panel II, lane 9). Its sedimentation behaviour is iden-
tical to the one of native/dimericmouse liverACOX1 (figure 1b,
panel V, bands marked ACOX1a/b/c in lane 9). This species is
hereafter referred to as dimeric ACOX1 (dACOX1). Centrifu-
gation of the two 35S-labelled ACOX1 populations in the
presence of recombinant PEX5 resulted in a slight increase in
their sedimentation coefficients (figure 1b, panel III), suggest-
ing that both species interact with PEX5. In agreement with
the data shown in figure 1a, less dACOX1 was generated in
translation reactions chased for 4 h in the presence of PEX5.
In this case, the major ACOX1 population was detected in frac-
tions 7–8, a behaviour identical to the one observed formACOX1 in the sucrose gradient containing PEX5 (figure 1b,
compare panels III and IV).
To further characterize the two ACOX1 populations
detected in these experiments their resistance to proteolysis
was assessed. As shown in figure 1c (left panel) 35S-mACOX1
is quite sensitive to proteinase K. By contrast, 35S-dACOX1 is
cleaved by the protease into a major 51 kDa fragment plus
three fragments of 40, 32 and 21 kDa (figure 1c, right panel).
Importantly, an almost identical proteolysis pattern was
obtained for native mouse liver dimeric ACOX1, as assessed
by western blotting using antibodies directed to the 53 kDa
and 21 kDa polypeptides (figure 1d). The only difference
between the 35S-dACOX1 species and endogenous mouse
dACOX1after protease treatment resides in the relative intensity
of the 21 kDa fragment which is barely detectable in the
35S-labelled protein. The fact that this domain of ACOX1 con-
tains only one of the 19 methionines present in full-length
ACOX1 justifies this difference.
In summary, the experiments described above suggest the
following: (i) ACOX1 synthesized in vitro for a short period of
time is a globular monomeric protease-sensitive protein;
(ii) further incubation of in vitro synthesized mACOX1 results
in its partial conversion into dACOX1; and (iii) PEX5 inhibits
ACOX1 dimerization.3.2. Peroxisomal in vitro import efficiencies of mACOX1
and dACOX1
We next tested the peroxisomal import efficiencies of
35S-mACOX1 and 35S-dACOX1 using an established in vitro
import system. For this purpose mACOX1 and dACOX1
obtained from a sucrose gradient as the one presented in
figure 1b (panel II) were incubated with a rat liver post-nuclear
supernatant (PNS) in import buffer supplemented with 1.5 nM
recombinant PEX5 (see Material and methods for details). Two
control import reactions were included in these experiments. In
the first, the import buffer contained also 300 nM of a recombi-
nant protein comprising the C-terminal half of PEX5 (hereafter
referred to as TPRs). This truncated PEX5 protein retains the
capacity to interactwith PTS1-containing proteins but lacks per-
oxisomal targeting information [68]. Thus, if the concentration
of TPRs is much larger than the concentration of PEX5 in the
assays then import of 35S-labelled ACOX1 should be strongly
inhibited. The second control reaction received 300 nM of an
inactive version of TPRs (TPRs(N526K)), a protein containing
a single missense mutation (N526K) that abolishes its PTS1-
binding capacity [18,69]. This recombinant protein should not
inhibit PEX5-dependent import of ACOX1. At the end of the
incubation, import reactions were treated or not with a large
amount of proteinaseK and the organelleswere isolated by cen-
trifugation and analysed by SDS-PAGE/autoradiography. The
results of this experiment are shown in figure 2a. Approximately
50% of mACOX1 sedimenting with the organelles acquired
a protease-resistant status (compare lanes 1 and 7). An identi-
cal result was obtained in the reaction supplemented with
TPRs(N526K) (compare lanes 3 and 9), as expected. By contrast,
the amount of protease-protectedmACOX1 in the reaction sup-
plemented with TPRs was strongly diminished (compare lanes
7 and 8). A different result was obtained for dACOX1. Indeed,
although a significant fraction of this protein sedimented with
the organelles (lanes 4–6), the vastmajorityof it remained acces-
sible to the protease (lanes 10–12), indicating that it was not
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Figure 1. (Caption opposite.)
rsob.royalsocietypublishing.org
Open
Biol.5:140236
4
 on December 14, 2017http://rsob.royalsocietypublishing.org/Downloaded from translocated across amembrane. Note that a very small amount
of intact dACOX1 is detected in these samples. However, this
material is unresponsive to recombinant TPRs (compare lane11 with lanes 10 and 12) and, therefore, it does not represent
authentic imported protein. In agreement with this interpret-
ation, the amount of uncleaved dACOX1 in import assays
Figure 1. (Opposite.) Newly synthesized ACOX1 dimerizes in vitro, a process inhibited by PEX5. (a) ACOX1 dimerizes in vitro. Upper panel: ACOX1 and HA-tagged
ACOX1 (2HA-ACOX1) were synthesized individually (lanes 1 and 2) or co-synthesized in the absence (2) or presence (þ) of 1 mM recombinant PEX5 (lanes 4 and 5,
respectively) for 30 min and subjected to a 4 h chase. A mixture of the two proteins synthesized individually (lane 3) and the co-synthesis reactions (lanes 4 and 5)
were subjected to immunoprecipitation (IP) using anti-HA antibody agarose beads (lanes 6–8, respectively). Note that all samples were made chemically identical
before immunoprecipitation by adding recombinant PEX5. Lower panel: An identical experiment was performed using 2HA-ACOX1 and ACOX1-Flag. IVT, in vitro
transcription/translation. (b) Sedimentation behaviour of in vitro synthesized ACOX1. ACOX1 synthesized for 30 min ( panel I), and ACOX1 synthesized for 30 min
and chased for 4 h in the absence ( panels II and III) or presence of 1 mM PEX5 (panel IV) were loaded onto the top of sucrose gradients supplemented
with 1 mM of either PEX5 (panels III and IV) or a control protein (panels I and II). After centrifugation, fractions were collected from the bottom of the gradients
and subjected to SDS-PAGE/autoradiography. Ovalbumin (OA), bovine serum albumin (BSA) and immunoglobulins (IgGs) were used as sedimentation coefficient
standards. Peroxisomal matrix proteins from mouse liver were also subjected to this analysis. A Coomassie-stained gel is shown (panel V). Carbamoyl phosphate
synthetase (CPS), 2-enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (EHHADH), acyl-CoA oxidase I subunits a, b and c (ACOX1a, ACOX1b, ACOX1c, respectively)
and catalase (Cat) were identified by nano-HPLC-MALDI-MS/MS (data not shown). (c) Monomeric and dimeric ACOX1 present different susceptibilities to proteinase
K. 35S-mACOX1 and 35S-dACOX1 isolated from a sucrose gradient were treated with increasing concentrations of proteinase K (PK) for 40 min on ice. After protease
inactivation, samples were analysed by SDS-PAGE/autoradiography. Numbers to the left indicate the molecular weights of protein standards. Arrow heads indicate
proteolysis fragments of ACOX1 (see main text). (d ) Dimeric 35S-ACOX1 and native/peroxisomal ACOX1 display the same proteolysis profile. 35S-dACOX1 isolated from
a sucrose gradient and native ACOX1 (from mouse liver purified peroxisomes) were subjected to protease treatment in the presence of Triton X-100 and subjected to
SDS-PAGE/autoradiography (left panel) or western blotting using antibodies directed to the 53-kDa ACOX1 polypeptide (central panel). The same blot was reprobed
with an antibody directed to the 21-kDa polypeptide of ACOX1 (right panel). F, front of the gel.
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Figure 2. mACOX1 is a better peroxisomal import substrate than dACOX1.
(a) 35S-mACOX1 and 35S-dACOX1 isolated from a sucrose gradient were sub-
jected to in vitro import reactions in the presence (þ) or absence (2) of the
indicated recombinant proteins. After incubation, one-half of each sample was
treated with proteinase K, as indicated. The organelles were then isolated and
analysed by SDS-PAGE/autoradiography. The autoradiograph (upper panel)
and the corresponding Ponceau S-stained membrane (lower panel) are
shown. I1, I2—5% of
35S-mACOX1 and 35S-dACOX1, respectively, used in
the assays. The arrow head indicates the 51 kDa protease-resistant fragment
of 35S-dACOX1. (b) Import kinetic analyses of 35S-mACOX1 and 35S-dACOX1.
The two import reactions (each containing 2.5 mg of PNS) were performed
in the presence of recombinant PEX5. Aliquots of each import reaction
(containing 500 mg of PNS) were withdrawn at the indicated time points,
treated with proteinase K and analysed as above. Note that the amount
of 35S-dACOX1 used in this experiment was approximately twofold that of
35S-mACOX1 to obtain similar substrate concentrations. Lanes I—5%
of the radiolabelled proteins present in each aliquot.
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(figure 2b).
Taken together, the results of these in vitro import exper-
iments, although of qualitative nature, strongly indicate that
mACOX1 is a far better substrate for the PIM than dACOX1.3.3. Urate oxidase behaves similarly to ACOX1 in the
in vitro homo-oligomerization and import assays
Aiming at extending the findings obtained with ACOX1
to another peroxisomal protein, we tested UOX in some of
the assays described above.UOX, an abundant protein compris-
ing 15% of the total protein molecules found in rat/mouse
liver peroxisomes, is a homo-tetramer of 35 kDa subunits in
its native state [63,64]. We first asked whether UOX can homo-
oligomerize in the rabbit reticulocyte lysate and, if so, whether
this process is inhibited by PEX5. The strategy used was exactly
the one described above for ACOX1 (figure 1a). As shown
in figure 3a, untagged UOX was co-immunoprecipitated with
2HA-UOX only when the two proteins were co-synthesized
in the absence of PEX5 (lane 7). Thus, PEX5 blocks UOX
oligomerization.
35S-UOX synthesized for just 45 min and 35S-UOX
subjected to a 4-h chase incubation were also analysed by
sucrose gradient centrifugation. As shown in figure 3b, the
first protein (hereafter referred to as monomeric UOX;
mUOX) sedimented slightly above ovalbumin, a 45 kDamono-
meric globular protein (panel I, lanes 4 and 5), whereas a
fraction of the protein thatwas allowed to oligomerize (referred
to as tetrameric UOX; tUOX) sedimented as authentic native/
tetrameric mouse liver UOX (panel II, lane 9; compare with
panel V in figure 1b). The two species of UOX display quite
different behaviours upon proteinase K treatment: mUOX is
readily degraded by the protease, whereas tUOX is largely
resistant yielding a diffuse doublet that runs slightly below
undigested UOX upon SDS-PAGE (figure 3c, left and right
panels, respectively).
Finally, 35S-mUOX and 35S-tUOX obtained from a sucrose
gradient were tested in in vitro import assays. The criteria to
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Figure 3. Behaviour of UOX in in vitro homo-oligomerization and import assays. (a) In vitro synthesized UOX oligomerizes in a process inhibited by PEX5. UOX and
HA-tagged UOX (2HA-UOX) were synthesized individually (lanes 1 and 2) or co-synthesized in the absence or presence of 1 mM recombinant PEX5 (lanes 4 and 5,
respectively) for 45 min, and subjected to a 4 h chase. A mixture of the two proteins synthesized individually (lane 3) and the co-synthesis reactions (lanes 4 and 5)
were subjected to immunoprecipitation (IP) using anti-HA antibody agarose beads (lanes 6–8, respectively) and analysed as described in figure 1a. IVT, in vitro
transcription/translation. (b) Sedimentation analyses of in vitro synthesized UOX. Radiolabelled UOX synthesized for 45 min ( panel I) or UOX synthesized for 45 min
and chased for 4 h (panel II) were subjected to sucrose gradient centrifugation analyses. The sedimentation positions of ovalbumin (OA), bovine serum albumin
(BSA) and immunoglobulins (IgGs) are also shown. (c) Monomeric and tetrameric UOX display different susceptibilities to protease treatment. 35S-mUOX and
35S-tUOX isolated from a sucrose gradient were subjected to proteinase K (PK) treatment (400 mg ml21, final concentration) and aliquots were withdrawn at
the indicated time points. Samples were processed as described in figure 1c. (d ) mUOX is a better substrate for the peroxisomal protein import machinery
than tUOX. 35S-mUOX and 35S-tUOX isolated from a sucrose gradient were subjected to in vitro import assays in the presence (þ) or absence (2) of the indicated
recombinant proteins. After incubation, one-half of each sample was treated with proteinase K, as indicated. Isolated organelles were processed and analysed
by SDS-PAGE/autoradiography. The autoradiograph (upper panel) and the corresponding Ponceau S-stained membrane (lower panel) are shown. I1, I2—5% of
35S-mUOX and 35S-tUOX, respectively, used in the assays. The arrow heads indicate protease-resistant fragments of 35S-tUOX.
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 on December 14, 2017http://rsob.royalsocietypublishing.org/Downloaded from define bona fide peroxisomal import were the ones used above
for ACOX1, i.e. acquisition of a protease-protected, organelle-
associated status in a TPRs-inhibitable manner. As shown in
figure 3d, a small amount of mUOX was imported into peroxi-
somes (cf. lanes 4 and 6 with 5). By contrast, wewere unable todetect specific peroxisomal import of tUOX. Indeed, the radio-
labelled protein appearing in the organelle pellets is insensitive
to the presence of TPRs in the assays (cf. lanes 10 and 11) and
runs as a diffuse doublet upon SDS-PAGE, indicating that it
is protease-accessible.
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can be imported into peroxisomes piggybacked
with ACOX1 containing the PTS1, but this pathway
is inefficient
The in vitro import assays described above suggest that
mACOX1 is a much better substrate for the PIM thandACOX1. An important question is whether this preference is
maintained under in vivo conditions. To address this issue,
we (co-)transfected COS-7 cells with plasmids encoding
two epitope-tagged versions of ACOX1, one containing a func-
tional PTS1 (2HA-ACOX1; see above) and the other lacking it
(ACOX1-Flag). Next, we investigated whether the first protein
can carry the second one to the peroxisome, and if so, with
what efficiency. Control experiments (figure 4a), in which
Figure 4. (Overleaf.) ACOX1 lacking a peroxisomal targeting signal is inefficiently imported into peroxisomes when co-expressed with ACOX1 containing a PTS1.
(a) COS-7 cells were transfected with plasmids encoding HA-tagged ACOX1 (2HA-ACOX1; panel I), a C-terminally Flag-tagged ACOX1 (ACOX1-Flag; panels II and III), or
a HA-tagged ACOX1 containing a nuclear targeting sequence (2HA-ACOX1–3NLS; panel IV). Two days post-transfection the cells were fixed, counterstained with
DAPI, and processed for immunofluorescence using an anti-PEX14 antibody (to label peroxisomes) and an anti-HA (panels I and IV) or anti-Flag antibody ( panels II
and III). Profile plots of fluorescence intensity (in percentage of pixel intensity) along the white arrows shown in the merged panels are also provided: blue line,
DAPI staining; green line, anti-PEX14 fluorescence; red line, anti-HA or anti-Flag fluorescence. Scale bar, 10 mm. (b) Expression levels of tagged ACOX1 proteins in
COS-7 cells. Untransfected cells (lanes ‘—’) or cells transfected with individual plasmids encoding ACOX1-Flag, 2HA-ACOX1 or 2HA-ACOX1–3NLS were analysed by
western blot using an antibody against the 53 kDa polypeptide of ACOX1. The arrow heads indicate the tagged ACOX1 proteins. (c) COS-7 cells were transfected with
mixtures of the plasmids encoding ACOX1-Flag and 2HA-ACOX1 at ratios of 1 : 10 and 1 : 30. Note that, as the total amount of plasmid in each of these mixtures was
adjusted to 1mg, ‘1’ corresponds to 10% and 3.3%, respectively, of the amount of plasmid DNA used in (a) and (b). The subcellular localization of each protein was
then analysed by immunofluorescence 1, 2 and 3 days post-transfection (dpt). Cells in which ACOX1-Flag displays an exclusive cytosolic localization (Cyt; see upper
panel for a representative example), a dual peroxisomal/cytosolic localization (PO/Cyt; middle panel), or an exclusive peroxisomal localization (PO; lower panel) were
counted and expressed as percentage of ACOX1-Flag-expressing cells in the bar graph. (d ) Exactly the same co-transfection strategy was used with plasmids encod-
ing 2HA-ACOX1–3NLS and ACOX1-Flag. Cells in which ACOX1-Flag displays an exclusive cytosolic localization (Cyt; see upper panel for a representative example), a
dual nuclear/cytosolic localization (Nuc/Cyt; middle panel) or an exclusive nuclear localization (Nuc; lower panel) were counted and expressed as percentage of
ACOX1-Flag-expressing cells in the bar graph. Note that at least 200 cells were analysed per condition. Scale bar, 10 mm.
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isomal (panel I) and cytosolic (panel II) staining pattern for
2HA-ACOX1 and ACOX1-Flag, respectively. Interestingly, in
a small number of cells (less than 5%), expression of ACOX1-
Flag also resulted in a staining pattern that partially, but very
weakly, overlapped with that of the peroxisomal marker
protein PEX14 (figure 4a, panel III), suggesting that a minor
amount of ACOX1-Flagwas imported into peroxisomes piggy-
backed with endogenous ACOX1 (see below). In agreement
with the peroxisomal localization observed for 2HA-ACOX1,
western blot analyses of total cell extracts using an antibody
directed to the 53 kDa polypeptide of ACOX1 revealed that
the majority of this protein ran below the intact 74 kDa
endogenous ACOX1 and immediately above its 53 kDa frag-
ment, indicating that it was cleaved in the peroxisomal matrix
(figure 4b). We next co-transfected cells with mixtures of the
two plasmids, and determined the subcellular localization of
each ACOX1 species by immunofluorescence at 1, 2 and 3
days post-transfection. To ensure that most ACOX1-Flag
produced in these cells had the possibility to interact with
newly synthesized 2HA-ACOX1, and thus to be imported
into peroxisomes, a 1 : 10 mixture of the expression plasmids
encoding ACOX1-Flag and 2HA-ACOX1, respectively, was
used. Under these conditions, an exclusive peroxisomal localiz-
ation was found for 2HA-ACOX1 regardless of the time point
at which the immunofluorescence analyses were performed.
By contrast, ACOX1-Flag displayed a cytosolic localization in
more than 90% of the cells analysed at 1 day post-transfection
(figure 4c, bar graph at the left-hand side). Interestingly, how-
ever, a small percentage of cells displayed a dual cytosolic and
peroxisomal localization for ACOX1-Flag at this time point.
The fraction of cells displaying such a distribution pattern
increased over the next 2 days, but an exclusive peroxisomal
localization for ACOX1-Flag could never be observed.
We were able to increase significantly the percentage of
cells presenting a peroxisomal localization for ACOX1-
Flag by transfecting cells with a 1 : 30 mixture of the plasmids
encoding ACOX1-Flag and 2HA-ACOX1, respectively. As
shown in figure 4c (bar graph at the right-hand side), an exclu-
sive peroxisomal localization for ACOX1-Flag was found in
approximately 5% of cells already at 1 day post-transfection.
Similarly to the results above, the fractionof cells presenting this
labelling pattern increased slowly during the two subsequent
days. Together, these experiments strongly indicate that
ACOX1-Flag can interact with 2HA-ACOX1 in the cytosoland use its PTS1 to reach the peroxisome. Thus, dimeric
ACOX1 is also a substrate for the PIM. However, it is also
evident from these data that targeting of ACOX1-Flag to
the peroxisome, in contrast to that of 2HA-ACOX1, is a
low-efficiency process occurring over a timescale of days.
The reason why ACOX1-Flag is poorly imported into the
organelle could reflect difficulties of the Flag-tagged protein
in interacting with 2HA-ACOX1. Although the in vitro oligo-
merization assay shown in figure 1a already suggests that
this is not the case, an in vivo approach was used to test this
possibility. Specifically, we co-expressed ACOX1-Flag with a
2HA-ACOX1 species containing three copies of a nuclear-
localization signal (NLS) at its C-terminus (thus blocking its
PTS1; see figure 4a, panel IV) in COS-7 cells and askedwhether
the nuclear targeted protein (2HA-ACOX1–3NLS) could trans-
port ACOX1-Flag to the nucleus. Similarly to the experiment
above, we used a 1 : 10 mixture of the plasmids encoding
ACOX1-Flag and 2HA-ACOX1–3NLS, respectively. As
shown in figure 4d, almost all ACOX1-Flag was found in the
nucleus, thus suggesting that the Flag epitopedoes not interfere
with the dimerization of ACOX1.4. Discussion
The idea that most newly synthesized peroxisomal proteins are
imported into the organelle after oligomerization in the cytosol
has remained widely accepted during the last two decades.
Besides all the studies referred to above that were used to
develop and support this concept (see Introduction section),
other arguments were frequently used to strengthen it. An
important one, which is nowadays questionable [70,71], was
that peroxisomes seemed to lack a protein-folding machinery
[45,48,55]. Thus, newly synthesized peroxisomal matrix pro-
teins should undergo folding and oligomerization in the
cytosol, where such a machinery exists. Data on human
alanine-glyoxylate amino transferase, a peroxisomal homo-
dimeric enzyme, seemed to provide the proof-of-concept for
this idea. Indeed, some mutations in the enzyme found in
hyperoxaluria type-1 patients lead to the mistargeting of a frac-
tion of the protein to the mitochondria. Since these mutations
also affect dimerization of the enzyme, it was thus concluded
that only the dimeric enzyme is competent for peroxiso-
mal import (reviewed in [72,73]). However, an identical
mistargeting phenomenon was recently described for human
over-expression/PIM rate-limiting
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Figure 5. Working model for the initial steps of the peroxisomal matrix protein import pathway. Newly synthesized proteins are bound by chaperones during or
immediately after their synthesis on cytosolic ribosomes. Successfully folded proteins are then released as near-native monomers and bound by cytosolic PEX5. These
monomers are transported to the peroxisomal matrix where oligomerization can occur. Peroxisomal matrix proteins that do not fold correctly (e.g. as a result of
mutation) are not released from the chaperones. Retained proteins may be degraded or mistargeted, as is the case of some mutant forms of alanine-glyoxylate
amino transferase and 2-enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase which target mitochondria [75,76]. Some proteins may also be imported after
oligomerization. This pathway may be particularly used when matrix proteins are overexpressed and the import machinery becomes rate-limiting. Note that
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(EHHADH), one of the few monomeric proteins of the peroxi-
somal matrix [74]. Indeed, studies in a family affected with
inherited renal Fanconi’s syndrome revealed that a single
missense mutation near the N-terminus of this enzyme was
sufficient to create a mitochondrial targeting sequence thus
resulting in its mitochondrial mistargeting [75]. Clearly,
there is no need to invoke a defect in the oligomerization of a
peroxisomal matrix protein to explain its mistargeting to mito-
chondria (see also [76] fora discussion on this issue). Rather, the
fact that a fraction of bothmutant enzymes ismissorted tomito-
chondria suggests that the mutations they harbour not only
create mitochondrial targeting information but also interfere
with their expedite folding, because only unfolded proteins
are accepted by the mitochondrial import machinery [77].
The data presented in this work add to a number of obser-
vations suggesting that several newly synthesized peroxisomal
matrix proteins arrive at the peroxisomal membrane still as
monomers. A particularly interesting finding of our work is
that both ACOX1 and UOX, similarly to catalase and sterol
carrier protein x [23,61], can be easily obtained in a soluble,
monomeric state. The solubility of all these proteins, together
with the fact that their hydrodynamicproperties are compatible
with a globular conformation, suggests that they are already
partially folded. With the exception of sterol carrier protein x,
for which no evidence for in vitro homo-dimerization could
be obtained thus far [23], monomeric ACOX1, UOX and cata-
lase can all be converted into the corresponding oligomers in
vitro. These findings suggest, on one hand, that these proteins
are bona fide assembly intermediates, and, on the other hand,
that (partial) folding and oligomerization of these monomeric
proteins are not obligatory coupled events. Importantly, thedata presented here show that the previously reported capacity
of PEX5 to bind monomeric catalase, blocking its oligomeriza-
tion [61], is also valid forACOX1 andUOX, twoproteinswhich
together with catalase comprise one-third of the total matrix
proteins found in rat/mouse liver peroxisomes [62,64].
Interestingly, in vitro import assays revealed that mono-
meric ACOX1 and UOX are more efficiently imported into
peroxisomes than the corresponding oligomeric versions.
The results of the co-transfection experiments presented in
figure 4, showing that HA-ACOX1 acquires a peroxisomal
localization in a much more efficient manner than ACOX1-
Flag, are also compatible with this interpretation. While
these findings suggest that the PIM displays a preference
for monomeric proteins, they do not unveil the mechanistic
reasons for such preference. Our in vivo data suggesting
that import of dimeric ACOX1 is a low-efficiency process
could be explained by simply assuming that interaction of
monomeric ACOX1 with PEX5 is a much faster event than
the dimerization of the enzyme in the cytosol. However,
the in vitro import assays presented here suggest that the pre-
ference of the PIM for monomeric proteins may also have
other reasons. For instance, it is possible that PEX5 binds
monomeric proteins in a faster/stronger manner than it
binds the corresponding oligomeric versions. Some data
suggesting that this may be the case for catalase have been
presented before [61]. Alternatively, the preference of the
PIM for monomeric proteins might be exerted by the DTM
itself. In this hypothetical scenario, the DTM would accept
monomeric proteins having a near-native (more flexible) con-
formation more efficiently than already oligomerized (rigid)
proteins. Discriminating between these possibilities will be
a difficult task, requiring much more than the presently
rsob.royalsocietypublishing.org
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that govern the peroxisomal protein import pathway.
Although there is still much to be learned on how newly
synthesized peroxisomal proteins are transported to the orga-
nelle matrix, the data presented here together with a number
of previous findings (see Introduction section) support a
model in which: (i) many newly synthesized peroxisomal
proteins are folded by cytosolic chaperones and released as
soluble monomers; (ii) these monomers are then bound by
cytosolic PEX5, which blocks their oligomerization; and
finally, (iii) these monomeric cargoes are translocated by a
single PEX5 molecule into the matrix of the organelle where
oligomerization occurs (figure 5).Biol.5:1402365. Material and methods
5.1. Plasmids and recombinant proteins
The cDNAs encoding mouse ACOX1 (clone ID 5704873, Open
Biosystems) and UOX (clone ID 5136328, Open Biosystems)
were amplified by PCR using the primers 50-GCTAATTCTA
GAGCCACCATGAATCCCGATCTG-30 and 50-CGCCGTGGT
ACCTAGCATCAAAGCTTCGACTG-30, and 50-GCAGCATC
TAGAGCCACCATGGCCCATTACC-30 and 50-CGCGCGGG
TACCTTTCACAGCCTGGAAGGCA-30, respectively, and
cloned into a XbaI/KpnI digested pGEM4w vector (Promega).
To generate the plasmid pGEM4–2HA-UOX, primers 50-AG
CTTACCATGGGCTACCCCTATGATGTGCCCGATTACGCC
TACCCATACGACGTCCCAGACTACGCTT-30 and 50-CTAG
AAGCGTAGTCTGGGACGTCGTATGGGTAGGCGTAATCG
GGCACATCATAGGGGTAGCCCATGGTA-30, encoding two
copies of the haemagglutinin (HA) tag, were annealed and
cloned into aHindIII/XbaI digestedpGEM4w vector (Promega),
originating pGEM4–2HA. Subsequently, the UOX cDNA
amplified using the primers 50-GCGCCGTCTAGAGCCCAT
TACCATGACAACT-30 and 50-CGCGCGGGTACC TTTCACA
GCCTGGAAGGCA-30 was inserted into the XbaI/KpnI sites
of the pGEM4–2HA. To generate the pGEM4–2HA-ACOX1
plasmid (pMF1636), the cDNA encoding mouse ACOX1 was
amplified by PCR (template: pGEM4–ACOX1; primers: 50-GG
AGGGTACCCATACGACGTCCCAGACTACGCTAATCCCG
ATCTGCGCAAG-30 and 50-GGGGAATTCAGCATCAAAGC
TTCGACTGCAGGGGC-30), digested with KpnI/EcoRI, and
co-ligated with a HindIII/KpnI site-containing linker (prepared
from the annealed oligonucleotides 50-AGCTTACCATGGG
CTACCCCTATGATGTGCCCGATTACGCCGGAGGGTAC-30
and 50-CCTCCGGCGTAATCGGGCACATCATAGGGGTAGC
CCATGGTA-30) into HindIII/EcoRI-restricted pGEM4. To gen-
erate the mammalian expression vector encoding 2HA-ACOX
(pMF1808), the corresponding cDNA was amplified by PCR
(template: pMF1636; primers: 50-GGGGAATTCACCATGGGC
TACCCCTATGATG-30 and 50-GGGGCGGCCGCTCAAAGCT
TCGACTGCAGGGGC-30), digested with EcoRI/NotI and
ligated into EcoRI/NotI-restricted pEGFP-N1 (Clontech).
To construct the mammalian expression vector encoding
ACOX1-Flag (pMF1809), the cDNA encoding ACOX1 was
amplified by PCR (template: pGEM4–ACOX1; primers: 50-G
GGGGCGGCCGCGCCACCATGGATCCCGATCTGCGCAA
GGAG-30 and 50-GGGGAATTCAGCATCAAAGCTTCGACT
GCAGGGGC-30), digested with NotI/HindIII and ligated
into pCMV-Tag4A (Stratagene). The mammalian expression
vector encoding 2HA-ACOX1–3NLS (pOI16) was generatedin two steps: first, a plasmid encoding myc-ACOX1–3NLS
(pCL5) was constructed by ligating an EcoRI/BglII-restricted
PCR fragment (template: pMF1636; primers: 50-GGGAATT
CGGATGGACCCCGATCTGCGCAAGG-30 and 50-GGAGAT
CTTCGACTGCAGGGGCTTCAAGTGC-30) into EcoRI/BglII-
restricted CL-Myc-DAO-3NLS (this plasmid was kindly
provided by Dr Y. M. Go (Tuffs University, MA, USA)); next,
the SalI/NotI fragment of pMF1808 was replaced by the SalI/
NotI fragment of pCL5. To generate pGEM4–ACOX1-Flag,
the corresponding cDNA was amplified by PCR (template:
pMF1809; primers: 50-GCTAATTCTAGAGCCACCATGAAT
CCCGATCTG-30 and 50-GCCGCGGGTACCAACTACTTATC
GTCGTCATCC-30) and subsequently cloned into the XbaI/
KpnI-restricted pGEM4w vector. The correctness of all plas-
mids was confirmed by DNA sequence analysis (LGC
Genomics). The recombinant large isoform of mouse PEX5
[61], a protein comprising amino acid residues 315–639 of
PEX5 (TPRs [78]), and TPRs containing the missense mutation
N526K (TPRs (N526K), numbering of full-length PEX5 [79])
were obtained as previously described.
5.2. Synthesis of radiolabelled proteins
35S-labelled proteins were synthesized using the TnT T7
QuickCoupled transcription/translation kit (Promega) in
the presence of 35S-methionine (specific activity . 1000
Ci mmol21; PerkinElmer Life Sciences). Protein synthesis
was allowed to proceed for the specified periods of time.
Cycloheximide was used at 0.5 mM, final concentration.
Chase incubations were performed at 308C, as specified.
5.3. Immunoprecipitations
Radiolabelled proteins synthesized in the presence of 1 mM
recombinant PEX5 were diluted to 500 ml with buffer A
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA–
NaOH, pH 8.0, 10% (w/v) glycerol, 0.1% (w/v) Triton X-100)
supplemented with 0.025% of bovine serum albumin (BSA)
and 1 : 500 (v/v) mammalian protease inhibitor mixture
(Sigma). The composition of translation product mixtures,
prepared in the presence and absence of PEX5, wasmade identi-
cal by adding recombinant PEX5. Immunoprecipitation was
done using 30 ml of anti-HA antibody agarose beads (Sigma)
for 3 h at 48C. Beads were washed four times with 150 ml
of buffer A. Immunoprecipitated proteins were analysed by
SDS-PAGE/autoradiography.
5.4. Sucrose gradients
Radiolabelled proteins were incubated for 5 min at room
temperature in the presence or absence of 1 mM of either
PEX5 or a control protein (soybean trypsin inhibitor), in
200 ml of buffer B (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
1 mM EDTA–NaOH, pH 8.0 and 1 mM DTT). The mixtures
were then loaded onto the top of a continuous 5–30%
(w/v) sucrose gradient in the same buffer (generated using
a 107ip GRADIENT MASTERTM; BioComp, Canada) and
centrifuged at 39 000 r.p.m. for 29 h at 48C in a SW-41
Rotor (Beckman). Where indicated, 1 mM of either PEX5
or soybean trypsin inhibitor was included in the gradient
solutions. Ovalbumin (3.6 S), BSA (4.3 S) and bovine immu-
noglobulins (6.9 S) were used as sedimentation coefficient
standards. Fractionation of gradients, SDS-PAGE and
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Mouse liver peroxisomal matrix proteins were obtained by
sonicating purified organelles (800 mg of protein) in buffer
B supplemented with 1 : 500 (v/v) mammalian protease
inhibitor mixture (Sigma) followed by centrifugation for
30 min at 100 000g. The supernatant was loaded onto the
top of a sucrose gradient and centrifuged, as above.
5.5. In vitro import reactions
Rat liver PNS was prepared as described before [22]. In vitro
import assays containing 500 mg of PNS and the radio-
labelled protein were incubated for 45 min at 378C, in
100 ml of import buffer (0.25 M sucrose, 20 mM MOPS-
KOH, pH 7.4, 50 mM KCl, 3 mM MgCl2, 20 mM methionine,
2 mg ml21 N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobu-
tylamide) containing 3 mM ATP, 2 mM glutathione, and
recombinant PEX5 (1.5 nM for ACOX1 and 7.5 nM for
UOX). Where indicated, TPRs or TPRs(N526K) (0.3 mM
final concentration) was also added to assays. Note that incu-
bation of radiolabelled ACOX1 and UOX with recombinant
PEX5 before proceeding with the import assay, a strategy
used before for sterol carrier protein x [23], resulted in only
a modest increase in the import yields of ACOX1 and UOX
(approx. 1.5-fold increase in 45 min import reactions). Thus,
for practical reasons, this step was not included in the exper-
iments described here. It is likely that the half-lives of the
PEX5–ACOX1 and PEX5–UOX protein complexes are too
short to benefit from this step, although further data are
necessary to confirm this possibility. Protease treatment of
import reactions was done using 400 mg ml21 of proteinase
K (final concentration) for 40 min, on ice. After protease inac-
tivation with phenylmethylsulfonyl fluoride (500 mg ml21,
final concentration) for 2 min on ice, organelles were isolated
by centrifugation and analysed as described before [28].
5.6. Cell culture, transfections and immunofluorescence
microscopy
COS-7 cells (kindly provided by Dr M. Schrader (University of
Exeter, UK)) were cultured at 378C in a humidified 5% CO2
incubator in minimum essential medium Eagle a (Lonza) sup-
plemented with 10% (v/v) fetal bovine serum superior
(Biochrom AG), 2 mM Ultraglutamine-1 (Lonza) and 0.2%
(v/v) Mycozap (Lonza). Cells were transfected using Invitro-
gen’s Neon Transfection System (1050 V, 30 ms pulse width, 1
pulse). Samples for immunofluorescence microscopy were
fixed and processed as described before [80]. The rabbit poly-
clonal antiserum against human PEX14 has been describedelsewhere [81]. DAPI (Roche), the mouse anti-HA (Sigma)
and anti-FLAG (Stratagene) antibodies, and the Alexa Fluor
488- (Invitrogen) or Texas Red- (Calbiochem) conjugated sec-
ondary antibodies were commercially obtained. Fluorescence
was evaluated on a motorized inverted IX-81 microscope
(Olympus) controlled byCell-M software (Olympus). The tech-
nical specifications of the objectives, excitation and emission
filters, and digital camera have been described elsewhere [82].
Fluorescence intensity versus distance plots (line scans) were
generated using IMAGEJ software.5.7. Miscellaneous
Isolation of highly pure peroxisomes from mouse liver by
differential centrifugation and Nycodenz gradient purification
was performed as described [83,84]. The antibodies directed to
the 21 kDa and 53 kDa fragments of ACOX1 have been
described before [85]. For the protease susceptibility assays,
35S-labelled proteins isolated from a sucrose gradient and
native ACOX1 (from mouse liver purified peroxisomes) were
diluted in import buffer and subjected to proteinase K diges-
tion (10–400 mg ml21, final concentration) in the presence or
absence of 1% (w/v) Triton X-100, as specified, and incubated
for 40 min on ice. After protease inactivation with phenyl-
methylsulfonyl fluoride, proteins were precipitated with
trichloroacetic acid and processed as previously described [22].
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